Cite
Chang PY, Huang CC, Hung CH, et al. Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer. 2018;7(4):312-322doi: 10.1159/000487608.
Chang, P. Y., Huang, C. C., Hung, C. H., Yu, C. Y., Wu, D. K., Hwang, J. I., Liang, P. C., Wu, R. H., Tsai, W. L., Lin, Y. J., Liu, Y. S., Liang, H. L., Lee, R. C., & Chen, C. H. (2018). Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver cancer, 7(4), 312-322. https://doi.org/10.1159/000487608
Chang, Pi-Yi, et al. "Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment." Liver cancer vol. 7,4 (2018): 312-322. doi: https://doi.org/10.1159/000487608
Chang PY, Huang CC, Hung CH, Yu CY, Wu DK, Hwang JI, Liang PC, Wu RH, Tsai WL, Lin YJ, Liu YS, Liang HL, Lee RC, Chen CH. Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer. 2018 Oct;7(4):312-322. doi: 10.1159/000487608. Epub 2018 Mar 29. PMID: 30488021; PMCID: PMC6249590.
Copy
Download .nbib